ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Q1 2014 13F Combination Report, Stock Holdings

Signature - Title
Anthony W. Ryan - President & Chief Executive Officer
Location
Boston, MA
Holdings as of
31 Mar 2014
Value $
$16,532,468
Num holdings
1,121
Filing time
15 May 2014, 16:19:49 UTC
Form type
13F-HR
Description
A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s). Top holdings included GLAXOSMITHKLINE PLC, TAIWAN SEMICONDUCTOR MFG LTD, VODAFONE GROUP PLC NEW, ASTRAZENECA PLC, and ABBVIE INC.
Previous filing
Q4 2013 - 14 Feb 2014
Next filing
Q2 2014 - 14 Aug 2014
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2014 Q1 compared to 2013 Q4 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Anthony W. Ryan President & Chief Executive Officer Boston, Massachusetts 15 May 2014

List of Other Managers Reporting for ARROWSTREET CAPITAL, LIMITED PARTNERSHIP:

Name Holdings Value Location File Number
RUSSELL FRANK CO/ $56,874,342,000 Seattle, WA 028-01190

Other Included Managers (1):

Num Name Location File Number
1 Arrowstreet Capital Holding LLC 028-104332